Sherita Hill Golden, MD

Call
Website

Photos

1800 Orleans St
Baltimore, MD 21287
+1 (410) 955-5000
https://www.hopkinsmedicine.org
Dr. Sherita Hill Golden is the Hugh P. McCormick Family Professor of Endocrinology and Metabolism. She holds joint appointments in the Welch Center for Prevention, Epidemiology, and Clinical Research, in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and in the Armstrong Institute for Patient Safety and Quality. An internationally recognized physician-scientist and member of the National Academy of Medicine, the Association of American Physicians, and the American Society of Clinical Investigation, Dr. Golden’s epidemiological research interests focus on two areas: (1) endogenous sex hormones as risk factors for CVD, type 2 diabetes, and insulin resistance in post-menopausal women and (2) mental health complications of diabetes and the biological, hormonal, and behavioral factors that might explain these associations. Her health services research focuses on understanding and eliminating diabetes health disparities and implementing and evaluating systems interventions to improve patient safety and quality of care in hospitalized patients with diabetes. She serves as the Principal Investigator of the Johns Hopkins site of the Diabetes Prevention Program Outcome Study.She is the author of more than 275 articles focused on diabetes, endocrinology, and health disparities. In order to more directly address the root causes of health inequities identified through her research, Dr. Golden has used her executive leadership roles to develop systems, community, and policy interventions. As inaugural Executive Vice-Chair of the Department of Medicine at Johns Hopkins School of Medicine (2015-2019), she launched a department-wide civic engagement initiative, resulting in programs that addressed community-related concerns and enhanced employee engagement following Baltimore’s civil unrest surrounding the 2015 death of Freddie Gray. During her tenure as Vice President and Chief Diversity Officer for Johns Hopkins Medicine (2019-2024), she oversaw diversity, inclusion, and health equity strategy and operations for the School of Medicine and Johns Hopkins Health System. This included staff training for accurate collection of self-identified patient demographic data; system-wide policies prohibiting patient discrimination and discriminatory aggression toward employees and trainees and allowing the use of chosen names on ID badges; a system-wide in-person and online unconscious bias and anti-oppression education programs; and a system-wide Disability and Accessibility Workgroup. In partnership with JHM Human Resources, she launched the Levi Watkins, Jr. Mentorship Program, which is designed as part of JHM’s talent management strategy focused on identifying and developing high-potential leaders, including those from underrepresented groups. During COVID-19 she facilitated mobile community testing and education for the underserved in Baltimore City and equitable vaccine distribution to non-clinical, minoritized frontline staff across JHM. Dr. Golden is a leader in the national discussion advancing health equity, including supporting Maryland legislators in drafting and testifying in support of state-level health equity policy. In 2017 she was the co-recipient of the Walter Reed Distinguished Achievement Award from the University of Virginia School of Medicine, Medical Alumni Association, and Medical School Foundation, which recognizes professional accomplishment, outstanding innovation, and exemplary leadership in the field of Medicine. In 2018 Dr. Golden was named a winner of the 17th Annual Women Worth Watching Awards from the Profiles in Diversity Journal. She was one of 132 winners from across the globe recognized as an executive leading the way to excellence in the workplace, marketplace, and the world. Dr. Golden is also the recipient of the 2019 University of Virginia Distinguished Alumna Award and in 2020 she was named a Maryland Top 100 Woman. She was named a 2021 Baltimore Sun 25 Woman to Watch and in 2022 was awarded the President’s Award from the University of Maryland Alumni Association for distinguished professional achievement.Dr. Golden graduated Phi Beta Kappa and summa cum laude from the University of Maryland, College Park, and Alpha Omega Alpha from the University of Virginia School of Medicine before training in Internal Medicine and Endocrinology, Diabetes, and Metabolism at the Johns Hopkins Hospital. During her endocrinology fellowship, she received a Master of Health Science degree in Clinical Epidemiology from the Johns Hopkins University Bloomberg School of Public Health where she was elected to the Delta Omega Public Health Honorary Society.
Request an Appointment

Also at this address

Owner verified
See a problem?

You might also like

Corina Noje, MD
Internal medicine practitioners

Corina Noje, MD

Dr. Corina Noje is an assistant professor of anesthesiology and critical care medicine at the Johns Hopkins University School of Medicine. Dr. Noje is a pediatric critical care clinician, educator, and program builder with expertise in pediatric critical care transport medicine. Dr. Noje came to Johns Hopkins in 2009 for her pediatric critical care fellowship and then joined the PICU faculty in July of 2012. In January 2014, she became Medical Director for Johns Hopkins Pediatric Transport (JHPT).Dr. Noje is interested in patient transport because of its diverse and versatile nature, as well as its high impact on patient outcomes. Evidence suggests that optimal care during the early acute illness is critical to long-term outcome. Therefore, delivering state-of-the-art care during transport can save precious time. The JHPT service receives requests from more than 60 centers in Maryland and neighboring states, as well as from facilities outside of the United States. They also coordinate pediatric transport out of Johns Hopkins. Her team must triage the patients, determine the mode of transportation (ambulance, helicopter, or airplane), and manage care while on the move, often with advanced modes of ventilation, ongoing hemodynamic and neurologic resuscitation, and even ECMO (extracorporeal membrane oxygenation) support. Her team also works to make palliative critical care transport feasible, thus enabling terminally ill children to spend their end of life at home with family. Critical care transport allows such patients to be transported home while still receiving artificial ventilation, hemodynamic support, and nutrition.Dr. Noje’s work focuses on expanding the JHPT service as well as optimizing transport triage and clinical management of the critically ill child in transport. Her interests include transport-specific clinical protocol development, use of telemedicine, pediatric in-transport resuscitation, optimal disposition of children transported with brain injury, pediatric palliative care transport program development, and staff/patient safety during interfacility pediatric ambulance transport. Her transport work contributed to consistent growth of the JHPT program, which received statewide recognition for delivering the highest quality, compassionate care to our region’s sickest children and was awarded the 2021 Outstanding Program of the Year Star of Life Award by MIEMSS.Dr. Noje’s transport expertise is recognized through publications on the transport of critically ill children, transport chapters in pediatric textbooks, requests to peer-review transport manuscripts in pediatric journals, and invitations to speak about her program and help organize national conferences on the topic of pediatric transport medicine. She is very involved with the American Academy of Pediatrics, Section on Transport Medicine, and was recently appointed its Membership Chair.Dr. Noje finds her work very rewarding because she is able to help the community, parents, and children by bringing patients to the place of definitive care and delivering excellent pediatric care both in transport and in the PICU. Moreover, she knows that the teams of transport paramedics and EMTs, respiratory therapists, PICU nurses, fellows, and attending physicians with whom she works spare nothing to provide the best care possible. In her free time, Dr. Noje enjoys spending time with her family, traveling, gardening, decorating, and listening to opera and classical music.Dr. Noje finished medical school in Bucharest, Romania, in 2005 at the University of Medicine and Pharmacy "Carol Davila". She then carried out her pediatric residency at St. Barnabas Hospital in New York from 2006 to 2009 and her pediatric critical care fellowship at Johns Hopkins from 2009 to 2012.
Thomas R Aversano, MD
Internal medicine practitioners

Thomas R Aversano, MD

Dr. Thomas R. Aversano is an associate professor of medicine at Johns Hopkins University. He is also the associate chief of cardiology at Johns Hopkins Cardiology at GBMC and the director of the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). His research interests focus on health services research - public policy, cardiovascular disease treatment, coronary intervention, and patient outcomes research in cardiovascular disease.Dr. Aversano received an undergraduate degree from the University of Rochester and a medical degree from the University of Oklahoma. He was a resident of internal medicine as well as a research fellow in cardiology at S.U.N.Y. at Buffalo before joining Johns Hopkins University as a cardiology fellow in 1982. Dr. Aversano has contributed to Johns Hopkins InHealth, specifically the development of a cardiology program (inCar) within the InHealth initiative focused on creation of a real-time decision-support, communication, and documentation tool for interventional cardiology.He also created and leads the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT) whose projects have involved 87 hospitals in 11 States and recruited more than 30,000 patients in randomized trials and registries. C-PORT worked with Departments of Health in 13 States to perform these studies. These projects were instrumental in changing both national heart association guidelines and State health care policy regarding performance of percutaneous coronary intervention (PCI).
Cynthia Louise Sears, MD

Cynthia Louise Sears, MD

An expert in foodborne and intestinal infections, Cynthia Sears is a professor of medicine and oncology at the Johns Hopkins University School of Medicine as well as a professor of molecular microbiology and immunology at the Bloomberg School of Public Health. She is the microbiome program leader of the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and is director of the Johns Hopkins Germ-free Murine Facility.She is an infectious diseases expert who has focused on gut infections including diarrhea, foodborne illnesses Clostridium difficile (C. diff) and Helicobacter pylori during her career. In the laboratory and in clinical settings, she has studied the pathogenesis of enterotoxigenic Bacteroides fragilis (ETBF) over the past 25 years. The current focus of the Sears laboratory is to determine how the microbiota and specific bacteria contribute to colon carcinogenesis. The Sears laboratory integrates studies in humans and mouse models, employing microbiology, bioinformatics and immunologic methods. Dr. Sears has worked abroad in Thailand, Brazil, Haiti, Bangladesh and Malaysia.Dr. Sears served as associate editor of Clinical Infectious Diseases from 2000 to 2016. She has been an active member of the Infectious Diseases Society of America (IDSA) for more than 20 years, serving the society in numerous capacities, and is currently president of the organization. Dr. Sears received her medical degree from Thomas Jefferson Medical College followed by training in internal medicine at The New York Hospital (Cornell Medical School) in New York City. She trained in infectious diseases at the Memorial Sloan Kettering Cancer Institute and the University of Virginia. Dr. Sears joined the faculty at the Johns Hopkins University School of Medicine in 1988.
United States›Maryland›Baltimore›Sherita Hill Golden, MD

Yext